LEXARIA BIOSCIENCE CORP (LEXX) Earnings History & Surprises

NASDAQ:LEXX • US52886N4060

1.04 USD

+0.05 (+5.05%)

Last: Apr 8, 2026, 11:28 AM

Past quarterly earnings results for LEXARIA BIOSCIENCE CORP (LEXX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Next Earnings Date

Upcoming

Release Date: Apr 13, 2026
Period: Q2 / 2026
EPS Estimate: -$0.10
Revenue Estimate: 51K

Last Reported

Most Recent

Release Date: Jan 13, 2026
Period: Q1 / 2026
EPS Reported: -$0.07
EPS Surprise: 47.21%
Revenue Surprise: -100.00%

Beat Rate

Last 8 Quarters

25%

EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

Quarter	EPS	EPS Est	EPS Surprise	EPS Q2Q	Revenue	Revenue Est	Revenue Surprise	Revenue Q2Q
Q1 2026	-0.07	-0.13	47.21%	56.25%		102K	-100.00%	-100.00%
Q4 2025	-0.13	-0.16	18.65%	7.14%	174K	139.74K	24.52%	107.14%
Q3 2025	-0.21	-0.16	-31.41%	-61.54%	174K	93.157K	86.78%	107.14%
Q2 2025	-0.15	-0.16	5.12%	-150.00%	174K	139.74K	24.52%	20.00%
Q1 2025	-0.16	-0.12	-30.72%	-23.08%	183.92K	102K	80.31%	21.56%
Q4 2024	-0.14	-0.11	-24.78%	-16.67%	84K	178.5K	-52.94%	-
Q3 2024	-0.13	-0.11	-23.34%	64.86%	84K	153K	-45.10%	-9.82%
Q2 2024	-0.06	-0.10	41.18%	-	145K		-	262.50%
Q1 2024	-0.13	-0.11	-15.86%	56.67%	151.3K		-	51.30%
Q4 2023	-0.12	-0.14	12.85%	50.00%		178.5K	-100.00%	-100.00%
Q3 2023	-0.37	-0.26	-45.10%	9.76%	93.15K	81.6K	14.15%	-6.85%
Q2 2023			-	-	40K		-	33.33%
Q1 2023	-0.30		-	-	100K		-	900.00%
Q4 2022	-0.24	-0.21	-12.04%	-10.09%	110K	198.9K	-44.70%	266.67%
Q3 2022	-0.41	-0.29	-43.56%	-2.50%	100K	122.4K	-18.30%	-50.00%
Q2 2022	-0.25	0.21	-216.71%	-	30K	153K	-80.39%	-84.21%
Q1 2022			-	-	10K		-	-96.67%
Q4 2021	-0.22	-0.23	7.08%	-	30K	255K	-88.24%	-50.00%
Q3 2021	-0.40		-	-	200K		-	400.00%
Q2 2021			-	-	190K		-	-5.00%
Q1 2021			-	-	300K		-	2,900.00%
Q4 2020			-	-	60K		-	-
Q3 2020			-	-	40K		-	-
Q2 2020			-	-	200K		-	-
Q1 2020			-	-	10K		-	-

Notes

EPS and Revenue values are non-GAAP when available, otherwise GAAP.
Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)

Average EPS beat (4)

9.89%

Max EPS beat (4)

47.21%

Min EPS beat (4)

-31.41%

Revenue beat statistics

Revenue beat (4)

Average Revenue beat (4)

8.95%

Max Revenue beat (4)

86.78%

Min Revenue beat (4)

-100.00%

Analysis

In the last 4 quarters, LEXX has beaten EPS estimates in 3 out of 4 releases

LEXX has beaten revenue estimates in 3 out of the last 4 releases

In the last 4 quarters, LEXX has beaten the EPS estimates by 9.9% on average.

In the last 4 quarters, LEXX has beaten the revenue estimates by 9.0% on average.

LEXX Overview LEXX Technical Analysis Report LEXX Fundamental Analysis Report LEXX Forecast & Price Target

→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

LEXARIA BIOSCIENCE CORP / LEXX Earnings FAQ

Can you provide the last earnings date for LEXARIA BIOSCIENCE CORP?

LEXARIA BIOSCIENCE CORP (LEXX) last reported earnings on 1/13/2026.

Did LEXX stock beat earnings estimates in the most recent quarter?

LEXARIA BIOSCIENCE CORP (LEXX) beat EPS estimates and missed revenue estimates in the most recent quarter.

How often does LEXARIA BIOSCIENCE CORP (LEXX) beat earnings estimates?

In the last 4 quarters, LEXARIA BIOSCIENCE CORP (LEXX) has beaten EPS estimates in 3 out of 4 releases.

LEXX Earnings overview

Earnings Snapshot